Sign in

CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475461709
Phone
(858) 684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-10-25 Carter Laura Chief Scientific Officer Sale −2,377 $12.25 $29K 95,306
2021-10-25 Aranda Richard Chief Medical Officer Sale −2,377 $12.25 $29K 217,432
2021-09-16 Giraudo Bryan COO/CFO Grant or award · Stock Option (Right to Buy) +150,000 150,000
2021-06-30 Carter Laura Chief Scientific Officer Grant or award +25,000 97,683
2021-06-21 Aranda Richard Chief Medical Officer Grant or award +15,000 219,809
2021-06-21 Aranda Richard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +30,000 30,000
2021-06-10 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +47,000 47,000
2021-06-09 Bilenker Joshua H. Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2021-06-09 Burow Kristina Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2021-06-09 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2021-06-09 GALA RENEE D Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2021-06-09 Cox Russell J. Director Grant or award · Stock Option (Right to Buy) +23,500 23,500
2021-05-03 Carter Laura Chief Scientific Officer Grant or award +10,820 72,683
2021-05-03 Carter Laura Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +31,750 31,750
2021-04-16 Peterson Caryn EVP, Regulatory Affairs Grant or award +10,820 74,828
2021-04-16 Peterson Caryn EVP, Regulatory Affairs Grant or award · Stock Option (Right to Buy) +31,750 31,750
2021-03-23 Salter-Cid Luisa Chief Scientific Officer Sale −5,491 $9.48 $52K 206,065
2021-03-23 Giraudo Bryan Chief Financial Officer Sale −5,490 $9.48 $52K 109,889
2021-03-23 Christian Waage EVP & General Counsel Sale −5,490 $9.48 $52K 588,199
2021-02-25 Hasnain Faheem President & CEO Grant or award +162,500 162,500

Page 16 of 21 · 401 trades